Panipenem

This classification denotes a beta-lactam antibiotic with the molecular formula C15H21N3O4S, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier W9769W09JF, chemically known as 1-azabicyclo(3.2.0)hept-2-ene-2-carboxylic acid, 6-(1-hydroxyethyl)-3-((1-(1-iminoethyl)-3-pyrrolidinyl)thio)-7-oxo-, (5r-(3(s*),5-alpha,6-alpha(r*)))- but generally known as panipenem, which bears US NIH Compound Identifier 72015. European Medicines Agency schedules Panipenem in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB09605MIG. The term PANIPENEM is an International Non-Proprietary Name. PANIPENEM is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule panipenem under HS 29419000 and SITC 54139. As of Q4 2014, PANIPENEM remains the US FDA Preferred Term for this commodity. Panipenem bears US NLM identifiers UMLS ID C0207932 and NCI Concept Code C66303. SMILES: S(C1=C(N2C(C(C2=O)C(O)C)C1)C(=O)O)C1CCN(C1)C(=N)C.